J Gynecol Oncol.  2021 Jan;32(1):e210. 10.3802/jgo.2021.32.e20.

The role of secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer: what do the trials tell us?

Affiliations
  • 1Department of Gynecologic Oncology, US Oncology Research, The Woodlands, TX, USA

Full Text Links
  • JGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr